Dubai Telegraph - Who should get paid for nature's sequenced genes?

EUR -
AED 3.865039
AFN 71.961868
ALL 97.885367
AMD 409.705534
ANG 1.898038
AOA 960.733931
ARS 1055.061215
AUD 1.613881
AWG 1.894109
AZN 1.787029
BAM 1.951539
BBD 2.126437
BDT 125.855234
BGN 1.956342
BHD 0.396578
BIF 3110.579445
BMD 1.052283
BND 1.414399
BOB 7.293078
BRL 6.086683
BSD 1.053191
BTN 88.848028
BWP 14.387453
BYN 3.446543
BYR 20624.740218
BZD 2.122845
CAD 1.469502
CDF 3014.78969
CHF 0.929776
CLF 0.037101
CLP 1023.776253
CNY 7.619996
CNH 7.625593
COP 4626.455438
CRC 534.824751
CUC 1.052283
CUP 27.885491
CVE 110.024795
CZK 25.350861
DJF 187.538784
DKK 7.458788
DOP 63.520417
DZD 140.573397
EGP 52.274979
ERN 15.78424
ETB 131.306162
FJD 2.388363
FKP 0.830585
GBP 0.832524
GEL 2.883571
GGP 0.830585
GHS 16.7185
GIP 0.830585
GMD 74.71233
GNF 9078.051459
GTQ 8.13025
GYD 220.338958
HKD 8.189863
HNL 26.613518
HRK 7.506205
HTG 138.346648
HUF 411.186809
IDR 16734.714279
ILS 3.929639
IMP 0.830585
INR 88.911049
IQD 1379.588093
IRR 44293.214291
ISK 145.520299
JEP 0.830585
JMD 166.933965
JOD 0.746386
JPY 162.676061
KES 136.007134
KGS 91.02957
KHR 4249.68174
KMF 491.94202
KPW 947.053999
KRW 1471.222726
KWD 0.323672
KYD 0.877684
KZT 523.167824
LAK 23125.51255
LBP 94319.785398
LKR 306.411046
LRD 190.622024
LSL 19.101997
LTL 3.107117
LVL 0.636515
LYD 5.138732
MAD 10.521031
MDL 19.167154
MGA 4930.189594
MKD 61.546561
MMK 3417.773046
MNT 3575.656436
MOP 8.443666
MRU 41.866002
MUR 48.839087
MVR 16.268296
MWK 1826.195708
MXN 21.380416
MYR 4.698412
MZN 67.293799
NAD 19.101997
NGN 1768.455747
NIO 38.755022
NOK 11.613586
NPR 142.154623
NZD 1.792324
OMR 0.40513
PAB 1.053101
PEN 3.996674
PGK 4.239684
PHP 62.126243
PKR 292.773138
PLN 4.342422
PYG 8247.914831
QAR 3.840515
RON 4.977085
RSD 117.020141
RUB 106.281009
RWF 1452.315514
SAR 3.95054
SBD 8.79238
SCR 14.332083
SDG 632.944958
SEK 11.610939
SGD 1.413951
SHP 0.830585
SLE 23.75528
SLL 22065.84631
SOS 601.88026
SRD 37.282669
STD 21780.126598
SVC 9.214882
SYP 2643.891613
SZL 19.091139
THB 36.458458
TJS 11.216013
TMT 3.682989
TND 3.324243
TOP 2.464553
TRY 36.27081
TTD 7.130433
TWD 34.270209
TZS 2791.031424
UAH 43.426878
UGX 3886.514989
USD 1.052283
UYU 45.021709
UZS 13526.469111
VES 48.861031
VND 26751.65603
VUV 124.929112
WST 2.937543
XAF 654.521833
XAG 0.033884
XAU 0.000395
XCD 2.843846
XDR 0.801343
XOF 654.521833
XPF 119.331742
YER 262.991742
ZAR 19.064031
ZMK 9471.810193
ZMW 29.146091
ZWL 338.834589
  • CMSC

    -0.0450

    24.52

    -0.18%

  • CMSD

    -0.0836

    24.26

    -0.34%

  • BCC

    -0.7700

    137.41

    -0.56%

  • SCS

    -0.0200

    13.07

    -0.15%

  • NGG

    -0.3100

    63.27

    -0.49%

  • RBGPF

    59.6900

    59.69

    +100%

  • AZN

    -0.6000

    63.2

    -0.95%

  • RIO

    -0.0400

    62.39

    -0.06%

  • BP

    -0.0100

    29.08

    -0.03%

  • GSK

    -0.1100

    33.35

    -0.33%

  • BTI

    0.1500

    37.08

    +0.4%

  • JRI

    -0.0300

    13.23

    -0.23%

  • RYCEF

    -0.0800

    6.61

    -1.21%

  • BCE

    -0.3100

    27

    -1.15%

  • RELX

    -0.1800

    45.11

    -0.4%

  • VOD

    0.0200

    8.94

    +0.22%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Sharma--DT